Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Kansas sues Pfizer alleging it ‘misled' the public about safety of COVID vaccine
02:00am, Tuesday, 18'th Jun 2024
Kansas Attorney General Kris Kobach says Pfizer ‘violated' the Consumer Protection Act on ‘The Bottom Line.' #foxbusiness #thebottomline
Merck's vaccine approval poses threat to one of Pfizer's top-selling products
05:06pm, Monday, 17'th Jun 2024
Merck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products.
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
04:10pm, Monday, 17'th Jun 2024
The lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer concealed evidence that the shot was linked to pregnancy complications, including miscarriage, as well as
Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit
02:51pm, Monday, 17'th Jun 2024
The U.S. state of Kansas on Monday sued Pfizer , accusing the company of misleading the public about its COVID-19 vaccine by hiding risks while making false claims about its effectiveness.
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday?
01:22pm, Monday, 17'th Jun 2024
BioNTech SE's BNTX partner MediLink Therapeutics (Suzhou) Co., Ltd says the FDA has placed a partial clinical hold on the Phase 1 trial.
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading Claims
01:13pm, Monday, 17'th Jun 2024
The state of Kansas has reportedly filed a lawsuit against pharmaceutical giant Pfizer, Inc. PFE, accusing the company of violating consumer protection laws related to its COVID-19 vaccine.
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
06:00am, Monday, 17'th Jun 2024
Pfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. In contrast, Merck stock is up 36% over this period.
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
05:57pm, Saturday, 15'th Jun 2024
Pfizer stock has been beaten down so far that it offers a dividend yield above 6% at recent prices. Bristol Myers Squibb has been trading for the low multiple of about 7 times trailing free cash flow.
Is It Too Late to Buy Pfizer Stock?
07:15am, Friday, 14'th Jun 2024
Pfizer's recent financial performance has some investors questioning its future. The critics aren't entirely wrong -- the pharmaceutical giant does face challenges.
3 Stocks to Sell as Ozempic Surges in Popularity
06:37am, Friday, 14'th Jun 2024
Novo Nordisk's (NYSE: NVO ) Ozempic diabetes treatment, marketed as a weight loss treatment under the Wegovy brand name, has become the latest mega-blockbuster drug. Yet, while you may be thinking abo
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma
03:00am, Friday, 14'th Jun 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
09:47am, Thursday, 13'th Jun 2024
Pfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory boys with DMD treated with its gene therapy fordadistrogene movaparvovec compared to placebo.
Dividend Harvesting Portfolio Week 171: $17,100 Allocated, $1,524.12 In Projected Dividends
09:00am, Thursday, 13'th Jun 2024
The markets had a strong week, with the S&P 500 gaining 0.97% and the Dow Jones Industrial Average gaining 1.6%. Yields on the 10-year Treasury shot up to 4.9% ahead of the FOMC meeting. The Dividend
Pfizer's gene-therapy trial failure boosts Sarepta's stock
08:49am, Thursday, 13'th Jun 2024
Shares of Sarepta Therapeutics Inc. SRPT, -1.15% gained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial.
Wells Fargo Has 6 Blue Chip High-Yield Passive Income Stocks That Yield Up to 6.5%
08:44am, Thursday, 13'th Jun 2024
24/7 Insights Dividend stocks are one of the best ideas to generate passive income.
